Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.
NCT ID: NCT02750982
Last Updated: 2018-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2016-07-31
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hybrid Approach to Mirror Therapy and Transcranial Direct Current Stimulation for Stroke Recovery
NCT02254616
Combining tDCS and CILT in Non-fluent Aphasia
NCT05561400
Mirror Therapy in Pos Stroke Individuals
NCT03175237
Neural Mechanisms and Efficacy of Dual Neurotechnology-aided Mirror Therapy in Chronic Stroke: Neural and Motor Plasticity, Movement Performance, Daily Function, and Quality of Life
NCT04326205
Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery
NCT04166968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laughter therapy
effects of Laughter therapy (LT) on mood, self-efficacy and other wellness measures in people with neurological conditions.
Laughter Therapy
Laughter Therapy (LT) involves simple exercises using playfulness, eye contact and chanting in forms of laughter. LT will be taught by a certified LT instructor in a group session. There will be 8 sessions per group with each session attended by 8-12 participants and lasting 60 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laughter Therapy
Laughter Therapy (LT) involves simple exercises using playfulness, eye contact and chanting in forms of laughter. LT will be taught by a certified LT instructor in a group session. There will be 8 sessions per group with each session attended by 8-12 participants and lasting 60 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Medically stable for at least 2 months.
* Not participating in Laughter therapy for 30 days prior to screening.
Exclusion Criteria
* Any unstable medical condition
* Severe cognitive deficits that would interfere with participation (e.g. unable to follow commands).
* Severe abdominal pain, chest pain or back pain.
* Abdominal, chest or back surgery within 90 days.
* Psychosis or severe mental illness.
* Untreated hernia.
* Persistent cough.
* Advanced hemorrhoids.
* Epilepsy.
* Uncontrolled Hypertension - SBP \>170 or DBP \>105.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brown, Theodore R., M.D., MPH
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Theodore R Brown
M.D., MPH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodore R Brown, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Evergreen Healthcare
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Evergreen Healthcare
Kirkland, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRBROWN201601
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.